Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhusmita Behera

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Registry Management|June 1, 2023
Current and Emerging Informatics Initiatives Impactful to Cancer RegistriesDana E Rollison, Gary M Levin, Jeremy L Warner, et al.
Cancer Treatment and Research Communications|February 20, 2021
Impact of high-risk features for stage II adenocarcinoma of the appendixMehmet Akce, Katerina Zakka, McKenna Penley, et al.
Journal of Surgical Oncology|October 30, 2020
Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomesOlatunji B Alese, Katerina Zakka, Xingyue Huo, et al.
Clinical Lung Cancer|May 4, 2016
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive AdenocarcinomaMadhusmita Behera, Taofeek K Owonikoko, Anthony A Gal, et al.
The Oncologist|May 3, 2013
Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysisTaofeek K Owonikoko, Camille Ragin, Zhengjia Chen, et al.
Surgical Oncology|December 28, 2020
Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?Katerina Zakka, Shayla Williamson, Renjian Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic ReviewMadhusmita Behera, Rathi N Pillai, Taofeek K Owonikoko, et al.
Oral Oncology|July 26, 2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic reviewMadhusmita Behera, Taofeek K Owonikoko, Sungjin Kim, et al.
Journal of Hepatocellular Carcinoma|August 16, 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinomaKaterina Zakka, Renjian Jiang, Olatunji B Alese, et al.
Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Registry Management|June 1, 2023
Current and Emerging Informatics Initiatives Impactful to Cancer RegistriesDana E Rollison, Gary M Levin, Jeremy L Warner, et al.
Cancer Treatment and Research Communications|February 20, 2021
Impact of high-risk features for stage II adenocarcinoma of the appendixMehmet Akce, Katerina Zakka, McKenna Penley, et al.
Journal of Surgical Oncology|October 30, 2020
Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomesOlatunji B Alese, Katerina Zakka, Xingyue Huo, et al.
Clinical Lung Cancer|May 4, 2016
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive AdenocarcinomaMadhusmita Behera, Taofeek K Owonikoko, Anthony A Gal, et al.
The Oncologist|May 3, 2013
Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysisTaofeek K Owonikoko, Camille Ragin, Zhengjia Chen, et al.
Surgical Oncology|December 28, 2020
Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?Katerina Zakka, Shayla Williamson, Renjian Jiang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic ReviewMadhusmita Behera, Rathi N Pillai, Taofeek K Owonikoko, et al.
Oral Oncology|July 26, 2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic reviewMadhusmita Behera, Taofeek K Owonikoko, Sungjin Kim, et al.
Journal of Hepatocellular Carcinoma|August 16, 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinomaKaterina Zakka, Renjian Jiang, Olatunji B Alese, et al.
Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.
Pageof 9